Biogen Aktie

158,71USD -2,20USD -1,37%
Biogen für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 789617 / ISIN: US09062X1037
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,29
The Vanguard Group, Inc. 11,45
PRIMECAP Management Co. 11,20
PRIMECAP Management Co. 11,17
Vanguard Group, Inc. (Subfiler) 11,01
Vanguard PRIMECAP Fund 6,30
SSgA Funds Management, Inc. 5,04
State Street Corp. 5,04
BlackRock Fund Advisors 3,53
Wellington Management Co. LLP (Wellington Breakout) 3,43
Vanguard Total Stock Market ETF 3,16
Vanguard Health Care Fund 3,13
T. Rowe Price Investment Management, Inc. 2,92
Vanguard 500 Index Fund 2,65
Geode Capital Management LLC 2,48

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 7 400 9 100 9 610 8 725 7 570
Umsatz pro Mitarbeiter in Mio. EUR 1,72 1,36 1,08 1,08 1,24

Bilanz (in Mio. USD) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 8 382 6 887 7 857 9 791 6 859
Summe Anlagevermögen 18 853 17 732 16 021 14 763 19 986
Summe Aktiva 27 234 24 619 23 877 24 554 26 845

Bilanz (in Mio. USD) - Passiva

2019 2020 2021 2022 2023
Summe Fremdkapital 13 895 13 933 12 918 11 166 12 045
Summe Eigenkapital 13 339 10 686 10 960 13 388 14 799
Summe Passiva 27 234 24 619 23 877 24 554 26 845

Adresse

225 Binney Street, 02142 Cambridge
Telefon +1 (617) 679-2000
Internet http://www.biogen.com

Management

Adam Keeney
Executive VP & Head-Corporate Development
Anabella Villalobos
SVP-Biotherapeutic & Medicinal Sciences
Caroline D. Dorsa
Chairman
Christopher A. Viehbacher
President, Chief Executive Officer & Director
Chuck Triano
Head-Investor Relations
Daniel Quirk
Chief Medical Officer & Head-Medical Affairs
Eric K. Rowinsky
Independent Director
Ginger Gregory
Chief Human Resources Officer & Executive VP
Jake Elkins
Vice President & Head-Acute Neurology Research
Jane Grogan
Executive Vice President & Head-Research
Jesus B. Mantas
Independent Director
Lloyd B. Minor
Director
Maria C. Freire
Independent Director
Menelas NICOLAS Pangalos
Director
Michael E. Dambach
Treasurer & Vice President
Michael Hencke
Executive Director-Investor Relations
Michael R. McDonnell
Chief Financial Officer & Executive Vice President
Monish Patolawala
Independent Director
Nancy A. Simonian
Vice President-Medical Research & Development
Nicole Murphy
Head-Pharmaceutical Operations & Technology
Priya Singhal
Head-Development
Rachid Izzar
Executive Vice President
Robert Kilo
Account Director
Robin C. Kramer
Chief Accounting Officer & Senior Vice President
Stephen A. Sherwin
Independent Director
Susan H. Alexander
Chief Legal Officer & Executive Vice President
Susan Langer
Independent Director
Tom Holmes
Senior Director-External Manufacturing
Wendell C. Taylor
Secretary & Chief Counsel
William A. Hawkins
Independent Director
Xu Cheryl
Vice President-Public Policy & Government Affairs